SE0201544D0 - Novel compounds and thier use - Google Patents
Novel compounds and thier useInfo
- Publication number
- SE0201544D0 SE0201544D0 SE0201544A SE0201544A SE0201544D0 SE 0201544 D0 SE0201544 D0 SE 0201544D0 SE 0201544 A SE0201544 A SE 0201544A SE 0201544 A SE0201544 A SE 0201544A SE 0201544 D0 SE0201544 D0 SE 0201544D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- novel compounds
- compounds
- thier
- thier use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201544A SE0201544D0 (sv) | 2002-05-17 | 2002-05-17 | Novel compounds and thier use |
DE60305484T DE60305484T2 (de) | 2002-05-17 | 2003-05-16 | Verbindungen und deren verwendung als 5-ht inhibitoren |
SI200330377T SI1506185T1 (sl) | 2002-05-17 | 2003-05-16 | Spojine in njihova uporaba kot inhibitorji 5-HT |
NZ536409A NZ536409A (en) | 2002-05-17 | 2003-05-16 | New piperazine compounds and their use in the treatment of serotonin-related disorders |
PT03725958T PT1506185E (pt) | 2002-05-17 | 2003-05-16 | Compostos novos e sua utilizacao |
AT03725958T ATE327229T1 (de) | 2002-05-17 | 2003-05-16 | Verbindungen und deren verwendung als 5-ht inhibitore |
ZA200408975A ZA200408975B (en) | 2002-05-17 | 2003-05-16 | Novel compounds are their use. |
US10/440,011 US7229997B2 (en) | 2002-05-17 | 2003-05-16 | Compounds and their use |
DK03725958T DK1506185T3 (da) | 2002-05-17 | 2003-05-16 | Forbindelser og deres anvendelse som 5-HT-inhibitorer |
MXPA04011437A MXPA04011437A (es) | 2002-05-17 | 2003-05-16 | Nuevos compuestos y su uso. |
YU99804A RS99804A (en) | 2002-05-17 | 2003-05-16 | Novel compounds and their use |
ES03725958T ES2263971T3 (es) | 2002-05-17 | 2003-05-16 | Compuestos y su uso como inhibidores de 5-ht. |
EP03725958A EP1506185B1 (en) | 2002-05-17 | 2003-05-16 | Compounds and their use as inhibitors of 5-ht |
AU2003228196A AU2003228196B2 (en) | 2002-05-17 | 2003-05-16 | Novel compounds and their use |
CNB038112493A CN1329389C (zh) | 2002-05-17 | 2003-05-16 | 化合物和它们的用途 |
JP2004505369A JP4865221B2 (ja) | 2002-05-17 | 2003-05-16 | 新規化合物とそれらの使用 |
KR1020047018539A KR20050026702A (ko) | 2002-05-17 | 2003-05-16 | 신규한 화합물 및 이의 용도 |
PCT/SE2003/000795 WO2003097636A1 (en) | 2002-05-17 | 2003-05-16 | Novel compounds and their use |
EA200401526A EA007543B1 (ru) | 2002-05-17 | 2003-05-16 | Производные 4-(3-трифторметилпиридин-5-ил)пиперазина, фармацевтическая композиция, способы их получения и применение |
CA002483619A CA2483619A1 (en) | 2002-05-17 | 2003-05-16 | Novel compounds and their use |
BR0310077-4A BR0310077A (pt) | 2002-05-17 | 2003-05-16 | Novos compostos e sua utilização |
IL16497404A IL164974A0 (en) | 2002-05-17 | 2004-11-01 | Novel compounds and their use |
NO20045486A NO20045486L (no) | 2002-05-17 | 2004-12-16 | Nye forbindelser og deres anvendelse |
HK06103395A HK1084941A1 (en) | 2002-05-17 | 2006-03-17 | Compounds and their use |
CY20061101170T CY1105162T1 (el) | 2002-05-17 | 2006-08-23 | Ενωσεις και η χρηση τους ως αναστολεις 5-ητ |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201544A SE0201544D0 (sv) | 2002-05-17 | 2002-05-17 | Novel compounds and thier use |
US41003802P | 2002-09-12 | 2002-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0201544D0 true SE0201544D0 (sv) | 2002-05-17 |
Family
ID=29552452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0201544A SE0201544D0 (sv) | 2002-05-17 | 2002-05-17 | Novel compounds and thier use |
Country Status (25)
Country | Link |
---|---|
US (1) | US7229997B2 (sv) |
EP (1) | EP1506185B1 (sv) |
JP (1) | JP4865221B2 (sv) |
KR (1) | KR20050026702A (sv) |
CN (1) | CN1329389C (sv) |
AT (1) | ATE327229T1 (sv) |
AU (1) | AU2003228196B2 (sv) |
BR (1) | BR0310077A (sv) |
CA (1) | CA2483619A1 (sv) |
CY (1) | CY1105162T1 (sv) |
DE (1) | DE60305484T2 (sv) |
DK (1) | DK1506185T3 (sv) |
EA (1) | EA007543B1 (sv) |
ES (1) | ES2263971T3 (sv) |
HK (1) | HK1084941A1 (sv) |
IL (1) | IL164974A0 (sv) |
MX (1) | MXPA04011437A (sv) |
NO (1) | NO20045486L (sv) |
NZ (1) | NZ536409A (sv) |
PT (1) | PT1506185E (sv) |
RS (1) | RS99804A (sv) |
SE (1) | SE0201544D0 (sv) |
SI (1) | SI1506185T1 (sv) |
WO (1) | WO2003097636A1 (sv) |
ZA (1) | ZA200408975B (sv) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
EP1792629A4 (en) | 2004-08-25 | 2010-08-25 | Takeda Pharmaceutical | PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF |
GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
JP5121707B2 (ja) | 2005-07-04 | 2013-01-16 | ハイ ポイント ファーマシューティカルズ,エルエルシー | 新規医薬 |
AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
PE20081192A1 (es) * | 2006-03-24 | 2008-10-07 | Wyeth Corp | Tratamiento del dolor |
AU2007231011A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | New therapeutic combinations for the treatment of depression |
US8158617B2 (en) | 2006-05-16 | 2012-04-17 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
CA2659570C (en) * | 2006-05-29 | 2015-10-06 | High Point Pharmaceuticals, Llc | 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
WO2007149728A2 (en) * | 2006-06-20 | 2007-12-27 | Alcon Research, Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
WO2008052086A1 (en) * | 2006-10-24 | 2008-05-02 | Wyeth | Benzodioxane derivatives and uses thereof |
JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
WO2008128996A1 (en) | 2007-04-23 | 2008-10-30 | Janssen Pharmaceutica N.V. | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
SI2148873T1 (sl) | 2007-04-23 | 2013-01-31 | Janssen Pharmaceutica, N.V. | Derivati 4-alkoksipiridazina kot antagonisti receptorja dopamina 2 s hitro disociacijo |
EP2014656A3 (en) * | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
JP5520051B2 (ja) | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | 縮合ピリジン誘導体およびその用途 |
MX2011000043A (es) | 2008-07-03 | 2011-02-22 | Janssen Pharmaceutica Nv | 6-(1-piperazinil)-piridazinas sustituidas como antagonistas del receptor 5-ht6. |
ES2622161T3 (es) * | 2008-07-31 | 2017-07-05 | Janssen Pharmaceutica, N.V. | Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida |
TWI542592B (zh) | 2009-06-15 | 2016-07-21 | 武田藥品工業股份有限公司 | 吡並氮雜氧雜環庚烯衍生物 |
EP2510949A4 (en) | 2009-12-11 | 2013-11-13 | Astellas Pharma Inc | THERAPEUTICS FOR FIBROMYALGIA |
US20130267500A1 (en) | 2010-09-01 | 2013-10-10 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
WO2013010679A1 (en) * | 2011-07-15 | 2013-01-24 | Novartis Ag | Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4078063A (en) * | 1976-09-24 | 1978-03-07 | Merck & Co., Inc. | Piperazinylpyridines |
DE68912282T2 (de) * | 1988-11-24 | 1994-04-28 | Akzo Nv | 1-[Mono- oder bis(trifluormethyl)-2-pyridinyl]piperazine enthaltende pharmazeutische Zusammensetzungen. |
EP0580465A1 (fr) | 1992-06-25 | 1994-01-26 | Sanofi | Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés |
JPH0665203A (ja) * | 1992-06-25 | 1994-03-08 | Elf Sanofi | ピペラジンのヘテロ環誘導体 |
SE9202265D0 (sv) * | 1992-07-31 | 1992-07-31 | Kabi Pharmacia Ab | Novel- pyridyl and pyrimidylpiperazine derivatives |
JPH0797370A (ja) * | 1993-09-29 | 1995-04-11 | Asahi Chem Ind Co Ltd | 2−アルコキシピラジン誘導体およびその用途 |
WO1998033504A1 (en) * | 1997-02-03 | 1998-08-06 | Akzo Nobel N.V. | Treatment of urinary incontinence |
JP3989102B2 (ja) * | 1997-10-02 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 縮合ピリジン誘導体 |
UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
EP1335907B1 (en) * | 2000-11-20 | 2010-06-09 | Biovitrum AB (publ) | Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
US6498184B2 (en) * | 2000-12-05 | 2002-12-24 | Akzo Nobel N.V. | Serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
EP1213017A3 (en) * | 2000-12-05 | 2003-11-12 | Akzo Nobel N.V. | Use of a 5-HT2C receptor agonist for the treatment of hot flushes |
-
2002
- 2002-05-17 SE SE0201544A patent/SE0201544D0/sv unknown
-
2003
- 2003-05-16 KR KR1020047018539A patent/KR20050026702A/ko not_active Application Discontinuation
- 2003-05-16 BR BR0310077-4A patent/BR0310077A/pt not_active IP Right Cessation
- 2003-05-16 AU AU2003228196A patent/AU2003228196B2/en not_active Expired - Fee Related
- 2003-05-16 CN CNB038112493A patent/CN1329389C/zh not_active Expired - Fee Related
- 2003-05-16 CA CA002483619A patent/CA2483619A1/en not_active Abandoned
- 2003-05-16 PT PT03725958T patent/PT1506185E/pt unknown
- 2003-05-16 DE DE60305484T patent/DE60305484T2/de not_active Expired - Lifetime
- 2003-05-16 ZA ZA200408975A patent/ZA200408975B/en unknown
- 2003-05-16 ES ES03725958T patent/ES2263971T3/es not_active Expired - Lifetime
- 2003-05-16 EA EA200401526A patent/EA007543B1/ru not_active IP Right Cessation
- 2003-05-16 DK DK03725958T patent/DK1506185T3/da active
- 2003-05-16 US US10/440,011 patent/US7229997B2/en not_active Expired - Fee Related
- 2003-05-16 WO PCT/SE2003/000795 patent/WO2003097636A1/en active IP Right Grant
- 2003-05-16 AT AT03725958T patent/ATE327229T1/de not_active IP Right Cessation
- 2003-05-16 JP JP2004505369A patent/JP4865221B2/ja not_active Expired - Fee Related
- 2003-05-16 MX MXPA04011437A patent/MXPA04011437A/es active IP Right Grant
- 2003-05-16 SI SI200330377T patent/SI1506185T1/sl unknown
- 2003-05-16 RS YU99804A patent/RS99804A/sr unknown
- 2003-05-16 NZ NZ536409A patent/NZ536409A/en unknown
- 2003-05-16 EP EP03725958A patent/EP1506185B1/en not_active Expired - Lifetime
-
2004
- 2004-11-01 IL IL16497404A patent/IL164974A0/xx unknown
- 2004-12-16 NO NO20045486A patent/NO20045486L/no not_active Application Discontinuation
-
2006
- 2006-03-17 HK HK06103395A patent/HK1084941A1/xx not_active IP Right Cessation
- 2006-08-23 CY CY20061101170T patent/CY1105162T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2483619A1 (en) | 2003-11-27 |
ZA200408975B (en) | 2005-11-14 |
EA200401526A1 (ru) | 2005-04-28 |
KR20050026702A (ko) | 2005-03-15 |
EP1506185B1 (en) | 2006-05-24 |
CN1329389C (zh) | 2007-08-01 |
DE60305484T2 (de) | 2006-11-09 |
ATE327229T1 (de) | 2006-06-15 |
DE60305484D1 (de) | 2006-06-29 |
DK1506185T3 (da) | 2006-10-02 |
AU2003228196A1 (en) | 2003-12-02 |
MXPA04011437A (es) | 2005-02-17 |
RS99804A (en) | 2006-12-15 |
SI1506185T1 (sl) | 2006-10-31 |
PT1506185E (pt) | 2006-10-31 |
AU2003228196B2 (en) | 2009-12-17 |
NZ536409A (en) | 2007-11-30 |
US20030232814A1 (en) | 2003-12-18 |
HK1084941A1 (en) | 2006-08-11 |
ES2263971T3 (es) | 2006-12-16 |
NO20045486L (no) | 2005-02-02 |
US7229997B2 (en) | 2007-06-12 |
JP4865221B2 (ja) | 2012-02-01 |
EA007543B1 (ru) | 2006-10-27 |
CY1105162T1 (el) | 2010-03-03 |
JP2005529926A (ja) | 2005-10-06 |
IL164974A0 (en) | 2005-12-18 |
EP1506185A1 (en) | 2005-02-16 |
BR0310077A (pt) | 2005-02-22 |
CN1701068A (zh) | 2005-11-23 |
WO2003097636A1 (en) | 2003-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0201544D0 (sv) | Novel compounds and thier use | |
IS6658A (is) | Ný efnasambönd | |
SE0302760D0 (sv) | New compounds | |
SE0001899D0 (sv) | New compounds | |
PT1263724E (pt) | Novos compostos | |
IS2376B (is) | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi | |
SE0103836D0 (sv) | Novel compounds | |
ATE316083T1 (de) | Adamantanderivate | |
SE0300480D0 (sv) | Novel compounds | |
SE0302139D0 (sv) | Novel compounds | |
ATE386725T1 (de) | Heterocyclylverbindungen | |
TW200604197A (en) | New compounds | |
NO20020282L (no) | Nytt difenyl-piperidinderivat | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0101038D0 (sv) | Novel compounds | |
DE602004031410D1 (de) | Inden derivate als pharmazeutika | |
SE0203303D0 (sv) | Novel Compounds | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0303280D0 (sv) | Novel compounds | |
SE0302755D0 (sv) | Novel compounds | |
SE0202693D0 (sv) | Compounds | |
MY139613A (en) | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders | |
SE0403118D0 (sv) | New compounds 2 | |
SE0403117D0 (sv) | New compounds 1 | |
ATE374751T1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern |